Apellis Pharmaceuticals Inc logo

Apellis Pharmaceuticals Inc share price today

(APLS)

Apellis Pharmaceuticals Inc share price is $33.45 & ₹2,831.31 as on 6 Dec 2024, 2.30 'hrs' IST

$33.45

-0.68

(-1.99%)

Market is closed - opens 8 PM, 06 Dec 2024

View live Apellis Pharmaceuticals Inc share price in Dollar and Rupees. Guide to invest in Apellis Pharmaceuticals Inc from India. Also see the sentimental analysis on Indian investors investing in Apellis Pharmaceuticals Inc. Get details on the Indian mutual funds that are investing in Apellis Pharmaceuticals Inc. Get Analyst recommendations and forecasts along with all the Apellis Pharmaceuticals Inc's financials.

Apellis Pharmaceuticals Inc share price movements

  • $32.82
    $34.19

    Day's Volatility :4.02%

  • $24.34
    $73.80

    52 Weeks Volatility :67.02%

Apellis Pharmaceuticals Inc Returns

PeriodApellis Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
-18.51%
-5.7%
0.0%
6 Months
-17.14%
-0.8%
0.0%
1 Year
-47.77%
9.9%
0.0%
3 Years
-19.26%
10.7%
-19.7%

Apellis Pharmaceuticals Inc Key Statistics

in dollars & INR

Previous Close
$34.13
Open
$33.97
Today's High
$34.19
Today's Low
$32.815
Market Capitalization
$4.4B
Today's Volume
$5.0M
52 Week High
$73.8
52 Week Low
$24.34
Revenue TTM
$715.2M
EBITDA
$-221.5M
Earnings Per Share (EPS)
$-2.03
Profit Margin
-34.97%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-106.56%

How to invest in Apellis Pharmaceuticals Inc from India?

It is very easy for Indian residents to invest directly in Apellis Pharmaceuticals Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Apellis Pharmaceuticals Inc stock in both rupees (INR) and dollars (USD). Search for Apellis Pharmaceuticals Inc or APLS on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Apellis Pharmaceuticals Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Apellis Pharmaceuticals Inc shares which would translate to 0.025 fractional shares of Apellis Pharmaceuticals Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Apellis Pharmaceuticals Inc

-12.08%

Period: Sep 6, 2024 to Dec 5, 2024. Change in 30 Days versus previous period

Investment in Apellis Pharmaceuticals Inc from India has reduced in the last 30 days as on Dec 6, 2024. -12.08% less purchase transactions for Apellis Pharmaceuticals Inc in the last 30 days versus the previous period.

222%

Period: Sep 6, 2024 to Dec 5, 2024. Change in 30 Days versus previous period

Search volume for Apellis Pharmaceuticals Inc on INDmoney from India has grown in the last 30 days as on Dec 6, 2024. 222% more investors are searching Apellis Pharmaceuticals Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Apellis Pharmaceuticals Inc

  • Wellington Management Company LLP

    12.51%

  • EcoR1 Capital, LLC

    9.56%

  • venBio Select Advisor LLC

    8.93%

  • Vanguard Group Inc

    7.89%

  • BlackRock Inc

    4.66%

  • Deep Track Capital, LP

    3.54%

Analyst Recommendation on Apellis Pharmaceuticals Inc

Buy

    82%Buy

    17%Hold

    0%Sell

Based on 23 Wall street analysts offering stock ratings for Apellis Pharmaceuticals Inc(by analysts ranked 0 to 5 stars)

Based on 23 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
19
19
18
Hold
4
4
5
Sell
0
0
0

Analyst Forecast on Apellis Pharmaceuticals Inc

What analysts predicted

Upside of 36.77%

Current:

$33.45

Target:

$45.75

Insights on Apellis Pharmaceuticals Inc

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 199.68M → 196.83M (in $), with an average decrease of 1.4% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -37.65M → -57.44M (in $), with an average decrease of 52.6% per quarter
  • Vs ALNY

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 43.9% return, outperforming this stock by 90.8%
  • Vs VRTX

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 42.3% return, outperforming this stock by 58.7%

Apellis Pharmaceuticals Inc Technicals Summary

Sell

Neutral

Buy

Apellis Pharmaceuticals Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Apellis Pharmaceuticals Inc Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Apellis Pharmaceuticals Inc
16.02%
-17.14%
-47.77%
-19.26%
37.65%
Regeneron Pharmaceuticals, Inc.
-5.97%
-23.44%
-9.57%
20.91%
110.02%
Biontech Se
11.44%
18.44%
16.6%
-60.74%
309.79%
Alnylam Pharmaceuticals, Inc.
-7.77%
64.82%
42.06%
39.68%
108.61%
Vertex Pharmaceuticals Incorporated
-6.83%
-4.79%
29.94%
124.11%
109.65%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Apellis Pharmaceuticals Inc
NA
NA
NA
-1.67
-1.07
-0.16
NA
1.94
Regeneron Pharmaceuticals, Inc.
18.56
18.56
1.12
44.92
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.06
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.21
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Apellis Pharmaceuticals Inc
Buy
$4.4B
37.65%
NA
-34.97%
Regeneron Pharmaceuticals, Inc.
Buy
$82.9B
110.02%
18.56
33.61%
Biontech Se
Buy
$28.5B
309.79%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$32.7B
108.61%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$118.4B
109.65%
32.84
-4.51%

Apellis Pharmaceuticals Inc Dividend announcements

  • Apellis Pharmaceuticals Inc Earnings

    Apellis Pharmaceuticals Inc’s price-to-earnings ratio stands at None

    Read More

About Apellis Pharmaceuticals Inc

apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.
Organization
Apellis Pharmaceuticals Inc
Employees
702
CEO
Dr. Cedric Francois M.D., Ph.D.
Industry
Distribution Services

Management People of Apellis Pharmaceuticals Inc

NameTitle
Dr. Cedric Francois M.D., Ph.D.
Co-Founder, President, CEO & Director
Mr. Alec Machiels J.D., MBA
Co-Founder & Director
Mr. Timothy E. Sullivan
CFO & Treasurer
Mr. Adam J. Townsend
Chief Operating Officer
Mr. David O. Watson Esq., J.D.
General Counsel
Dr. Caroline R. Baumal M.D.
Chief Medical Officer
Dr. Pascal Deschatelets Ph.D.
Co-Founder & Chief Scientific Officer
Mr. James G. Chopas CPA
VP, Corporate Controller & Chief Accounting Officer
Ms. Meredith Kaya
Senior Vice President, Investor Relations & Strategic Finance
Ms. Karen Lewis
Chief People Officer

Important FAQs about investing in Apellis Pharmaceuticals Inc from India :

What is Apellis Pharmaceuticals Inc share price today?

Apellis Pharmaceuticals Inc (APLS) share price today is $33.45.

Can Indians buy Apellis Pharmaceuticals Inc shares?

Yes, Indians can invest in the Apellis Pharmaceuticals Inc (APLS) from India.

With INDmoney, you can buy Apellis Pharmaceuticals Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Apellis Pharmaceuticals Inc at zero transaction cost.

How can I buy Apellis Pharmaceuticals Inc shares from India?

It is very easy to buy Apellis Pharmaceuticals Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Apellis Pharmaceuticals Inc be purchased?

Yes, you can buy fractional shares of Apellis Pharmaceuticals Inc with INDmoney app.

What are the documents required to start investing in Apellis Pharmaceuticals Inc stocks?

To start investing in Apellis Pharmaceuticals Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Apellis Pharmaceuticals Inc

Today’s highest price of Apellis Pharmaceuticals Inc (APLS) is $34.19.

Today’s lowest price of Apellis Pharmaceuticals Inc (APLS) is $32.82.

What is today's market capitalisation of Apellis Pharmaceuticals Inc

Today's market capitalisation of Apellis Pharmaceuticals Inc APLS is 4.4B

What is the 52 Week High and Low Range of Apellis Pharmaceuticals Inc

  • 52 Week High

    $73.80

  • 52 Week Low

    $24.34

How much percentage Apellis Pharmaceuticals Inc is down from its 52 Week High?

Apellis Pharmaceuticals Inc (APLS) share price is $33.45. It is down by 99% from its 52 Week High price of $73.80.

How much percentage Apellis Pharmaceuticals Inc is up from its 52 Week low?

Apellis Pharmaceuticals Inc (APLS) share price is $33.45. It is up by 1% from its 52 Week Low price of $24.34.

What are the historical returns of Apellis Pharmaceuticals Inc?

  • 1 Month Returns

    16.02%

  • 3 Months Returns

    -17.14%

  • 1 Year Returns

    -47.77%

  • 5 Years Returns

    37.65%

Who is the Chief Executive Officer (CEO) of Apellis Pharmaceuticals Inc

Dr. Cedric Francois M.D., Ph.D. is the current Chief Executive Officer (CEO) of Apellis Pharmaceuticals Inc.